Does atrasentan improve coronary microvascular endothelial function in patients with early atherosclerosis?
Atrasentan improves coronary microvascular endothelial function in patients with early atherosclerosis, highlighting the role of the endothelin system.
This study demonstrates that 6-month treatment with atrasentan improves coronary microvascular endothelial function and supports the role of the endogenous endothelin system in the regulation of endothelial function in early atherosclerosis in humans. Clinical Trial Registration Information- URL: http://www.clinicaltrials.gov. Unique identifier: NCT00271492.
Reriani et al. (Mon,) studied this question.